>Глобальный рынок электронных клинических решений, по продуктам (электронные системы сбора данных и управления данными клинических испытаний, системы управления клиническими испытаниями, платформы клинической аналитики, медицинские записи для координации ухода (CCMR), рандомизация и управление поставками для испытаний, платформы интеграции клинических данных, электронные решения для оценки клинических результатов, решения по безопасности, электронные системы основных файлов испытаний, решения по управлению нормативной информацией и другие), способ доставки (решения, размещаемые в Интернете (по требованию), лицензированные корпоративные (локальные) решения и облачные (SAAS) решения), фаза клинических испытаний (фаза I, фаза II, фаза III и фаза IV), размер организации (малая, средняя и большая), пользовательское устройство (настольный компьютер, планшет, карманное устройство PDA, смартфон и другие), конечный пользователь (фармацевтические и биофармацевтические компании, организации по контрактным исследованиям, компании по оказанию консалтинговых услуг, производители медицинского оборудования, больницы и научно-исследовательские институты), Тенденции отрасли и прогноз до 2030 года.
Анализ и размер рынка электронных клинических решений
Глобальный рынок электронных клинических решений по своей природе фрагментирован, поскольку состоит из многих глобальных игроков, таких как Oracle, IQVIA Inc., Dassault Systemes и Clario и других. Присутствие этих компаний обеспечивает конкурентоспособные цены на системные услуги и программное обеспечение по всему региону. Благодаря присутствию этих игроков на региональном и международном уровнях поставщики и производители предлагают продукты с различными спецификациями и характеристиками для всех бюджетов. Растущее внедрение систем электронного сбора данных (EDC) и облачных технологий стимулирует рост рынка. Кроме того, ожидается, что растущее внимание к клиническим испытаниям, ориентированным на пациента, будет способствовать росту рынка.
Data Bridge Market Research анализирует, что ожидается, что глобальный рынок электронных клинических решений достигнет значения 20 022,42 млн долларов США к 2030 году, при среднегодовом темпе роста 13,5% в течение прогнозируемого периода. Этот рыночный отчет также подробно охватывает анализ цен и технологические достижения.
|
Отчет Метрика |
Подробности |
|
Прогнозируемый период |
2023-2030 |
|
Базовый год |
2022 |
|
Исторические годы |
2021 (Можно настроить на 2015–2020) |
|
Количественные единицы |
Доход в млн. долл. США, объемы в единицах и цены в долл. США |
|
Охваченные сегменты |
По продукту (электронные системы сбора данных и управления данными клинических испытаний, системы управления клиническими испытаниями, платформы клинической аналитики, медицинские записи для координации ухода (CCMR), рандомизация и управление поставками для испытаний, платформы интеграции клинических данных, электронные решения для оценки клинических результатов, решения по безопасности, электронные системы основных файлов испытаний, решения по управлению нормативной информацией и другие), способ доставки (решения, размещенные в Интернете (по запросу), лицензированные корпоративные (локальные) решения и облачные (SAAS) решения), фаза клинических испытаний (фаза I, фаза II, фаза III, фаза IV), размер организации (малая, средняя и большая), пользовательское устройство (настольный компьютер, планшет, карманное устройство PDA, смартфон и другие), конечный пользователь (фармацевтические и биофармацевтические компании, организации по контрактным исследованиям, компании по оказанию консалтинговых услуг, производители медицинского оборудования, больницы и научно-исследовательские институты) |
|
Страны, охваченные |
США, Канада, Мексика, Германия, Франция, Великобритания, Италия, Испания, Нидерланды, Россия, Швейцария, Турция, Бельгия, Остальная Европа, Китай, Япония, Индия, Южная Корея, Австралия, Сингапур, Таиланд, Малайзия, Индонезия, Филиппины, Остальная часть Азиатско-Тихоокеанского региона, Бразилия, Аргентина, Остальная часть Южной Америки, Южная Африка, Саудовская Аравия, ОАЭ, Египет, Израиль, Остальной Ближний Восток и Африка |
|
Охваченные участники рынка |
Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC, Y-Prime LLC, RealTime Software Solutions LLC, Quretec, Research Manager (Нидерланды), Datatrack Int. и IQVIA Inc.
|
Определение рынка
Целью электронных клинических решений является революция в области клинических исследований. Организация клинического управления пытается улучшить эффективность, результативность и доступность данных клинических исследований для более быстрого лечения пациентов. Идея создания электронных клинических решений заключалась в том, чтобы выявить проблемы с данными клинических исследований, исправить их и предложить креативные решения, чтобы сделать данные клинических испытаний полезными и простыми для получения и облегчить стандартизацию, отчетность и эксплуатацию области клинических исследований. Ожидается, что растущее принятие и растущее внимание к электронным клиническим решениям и программному обеспечению будут способствовать росту рынка.
Электронные клинические решения, такие как электронный сбор данных (EDC), электронные результаты, сообщенные пациентами (ePRO), системы управления клиническими испытаниями (CTMS) и электронные основные файлы испытаний (eTMF), представляют собой программное обеспечение, используемое в клинических исследованиях для управления клиническими данными. Однако ожидается, что строгие правила и стандарты для одобрения клинических испытаний и одобрения продуктов будут сдерживать рост рынка.
Динамика мирового рынка электронных клинических решений
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
Increasing R&D activities and corresponding expenditure
Research & development is crucial in all industries, including life science and healthcare. The life science industry carries out extensive research and development to generate revenue and often brings results that embrace saving or enhancing a patient's life. Drug development requires going through clinical trials to check clinical data analysis and review its study and new data insights.
The e-clinical solutions are used for comprehensive data review, automating the data transformation process, and analytics to accelerate timelines. Pharmaceutical and biopharmaceutical companies conduct many clinical trials to complete successful drug or biologic development. Pharmaceutical and biopharmaceutical companies have increased their focus on research and development, raising the demand for e-clinical solutions.
Improved healthcare infrastructure and establishment of advanced laboratories
Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population.
Infrastructure must integrate the hospital, as the acute and in-patient care center, into the broader healthcare system. It should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements such as equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff. This improved healthcare infrastructure and staff more opportunities for e-clinical solutions to grow and give better results.
OPPORTUNITY
Increasing investments by various governments in clinical trials
Clinical trial funding comes from various sources, including the government, commercial investors, nonprofit organizations, academic institutions, and other research organizations. Historically, the National Institutes of Health (NIH) has made the biggest government investments in fundamental drug development research. The defense advanced research agency (DARPA) has also contributed to the discovery stage by accepting a few relatively high-risk biologic initiatives. State governments are also increasingly taking the lead in this area, partly due to the public's frustration with the lengthy discovery process. Thus, government initiatives and investments toward discovering new drugs with trial studies are expected to create an opportunity for market growth.
RESTRAINT / CHALLENGE
Data Safety and Privacy issues
Information systems are heavily concerned with privacy and security. Access to individual health information is made possible by digitalizing healthcare services from any electronic device with an internet connection anywhere globally. Users typically are unaware of how their data is handled. Healthcare data on the cloud has caught the attention of hackers, who target systems to launch attacks and steal sensitive data in exchange for financial benefit.
Data breaches have been common since 2019, over 50 million electronic medical records have been hacked in 2021, and the number of security breaches was predicted to increase every year. The creation of inter-jurisdictional data-sharing agreements and the storage and manipulation of data holdings are significantly hampered by concerns about personal privacy and information confidentiality and the recent enactment of privacy and confidentiality legislation across the provinces and territories (exceptionally patient records). Thus, it is a restraint for the global e-clinical solutions market and is expected to hamper market growth.
Post-COVID-19 Impact on the Global e-Clinical Solutions Market
COVID-19 created a positive impact on the global e-clinical solutions market. The lockdown restriction led to the emergence of various opportunities such as drug development, EMR and EHR application installation, and many others.
However, increasing government support and advanced and innovative techniques are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel market growth. Also, the growth has been high since the market opened after COVID-19, and it is expected that there would be considerable growth in the sector. The market players are conducting multiple activities to improve the trial study techniques. With this, the companies will bring advancement and innovation to the market.
Recent Developments
- In April 2023, the Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe
- In March 2023, Clario has launched a cloud-based Image Viewer tool that helps the Sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering
Global e-Clinical Solutions Market Scope
The global e-clinical solutions market is segmented into six notable segments based on product, delivery mode, clinical trial phase, organization size, user device, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Electronic Data Capture and Clinical Data Management Systems
- Clinical Trial Management Systems
- Clinical Analytics Platforms
- Care Coordination Medical Record (CCMR)
- Randomization and Trial Supply Management
- Clinical Data Integration Platforms
- Electronic Clinical Outcome Assessment Solutions
- Safety Solutions
- Electronic Trial Master File Systems
- Regulatory Information Management Solutions
- Others
Based on product, the market is segmented into electronic data capture and clinical data management, clinical trial management systems, clinical analytics platforms, care coordination medical record (CCMR), randomization and trial supply management, clinical data integration platforms, electronic clinical outcome assessment solutions, safety solutions, electronic trial master file systems, regulatory information management solutions, and others.
Delivery Mode
- Web-Hosted (On-Demand) Solutions
- Licensed Enterprise (On-Premises) Solutions
- Cloud-based (SAAS) Solutions
Based on delivery mode, the market is segmented into web-hosted ( on-demand) solutions, licensed enterprise (on-premises) solutions, and cloud-based (SAAS) solutions.
Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Based on clinical trial phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV.
Organization Size
- Small & Medium
- Large
Based on organization size, the market is segmented into small & medium, and large.
User Device
- Desktop
- Tablet
- Handheld PDA Device
- Smart Phone
- Others
Based on user device, the market is segmented into desktop, tablet, handheld PDA device, smart phone, and others.
End User
- Pharmaceutical and Biopharmaceutical companies
- Contract Research Organizations
- Consulting Service Companies
- Medical Device Manufacturers
- Hospitals
- Academic Research Institutes
Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutes.
Global e-Clinical Solutions Market Regional Analysis/Insights
The global e-clinical solutions market is analyzed, and market size information is provided product, delivery mode, clinical trial phase, organization size, user device, and end user.
В данном отчете о рынке рассматриваются следующие страны: США, Канада, Мексика, Германия, Франция, Великобритания, Италия, Испания, Нидерланды, Россия, Швейцария, Турция, Бельгия, остальные страны Европы, Китай, Япония, Индия, Южная Корея, Австралия, Сингапур, Таиланд, Малайзия, Индонезия, Филиппины, остальные страны Азиатско-Тихоокеанского региона, Бразилия, Аргентина, остальные страны Южной Америки, Южная Африка, Саудовская Аравия, ОАЭ, Египет, Израиль, а также остальные страны Ближнего Востока и Африки.
Северная Америка доминирует из-за присутствия ключевых игроков на крупнейшем потребительском рынке с высоким ВВП. Ожидается, что США будут расти из-за своих новейших передовых технологий и изобретений на рынке электронных клинических решений.
Северная Америка доминирует на мировом рынке из-за растущих инвестиций в НИОКР для разработки лекарств, и ожидается, что доставка будет стимулировать рост рынка. США доминируют в Северной Америке из-за сильного присутствия ключевых игроков: Oracle, Dassault Systemes, Clario, MedNet и других. Германия доминирует в европейском регионе из-за растущего принятия электронных клинических решений. Япония доминирует в Азиатско-Тихоокеанском регионе из-за растущего внимания к испытаниям, ориентированным на пациента.
Раздел отчета, посвященный странам, также содержит индивидуальные факторы, влияющие на рынок, и изменения внутреннего регулирования, которые влияют на текущие и будущие тенденции рынка. Такие данные, как новые продажи, заменяющие продажи, демографические данные страны, нормативные акты и импортно-экспортные тарифы, являются одними из основных указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по стране учитываются наличие и доступность глобальных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и внутренних брендов, а также влияние каналов продаж.
Анализ конкурентной среды и доли мирового рынка электронных клинических решений
Конкурентная среда глобального рынка электронных клинических решений содержит сведения о конкуренте. Сведения включают обзор компании, финансы, полученный доход, рыночный потенциал, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широту и широту продукта и доминирование приложений. Приведенные выше данные относятся только к фокусу компаний на рынке.
К числу основных игроков, работающих на мировом рынке электронных клинических решений, относятся Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC, Y-Prime LLC и RealTime Software Solutions LLC и другие.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER'S FIVE FORCES MODEL
4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS
4.3 USE CASES
5 VALUE CHAIN ANALYSIS
6 GLOBAL E-CLINICAL SOLUTIONS MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS
7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE
7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES
7.2 RESTRAINTS
7.2.1 DATA SAFETY AND PRIVACY ISSUES
7.2.2 LACK OF SKILLED PROFESSIONALS
7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES
7.3 OPPORTUNITIES
7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS
7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS
7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS
7.4 CHALLENGES
7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS
7.4.2 HIGH IMPLEMENTATION COSTS
8 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS
8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS
8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
8.7 SAFETY SOLUTIONS
8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
8.9 CLINICAL DATA INTEGRATION PLATFORMS
8.1 CLINICAL ANALYTICS PLATFORMS
8.11 CARE COORDINATION MEDICAL RECORD (CCMR)
8.12 OTHERS
9 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE
9.1 OVERVIEW
9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
9.3 CLOUD-BASED (SAAS) SOLUTIONS
9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS
10 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
10.1 OVERVIEW
10.2 PHASE III
10.3 PHASE I
10.4 PHASE II
10.5 PHASE IV
11 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE
11.1 OVERVIEW
11.2 MEDIUM AND SMALL
11.3 LARGE
12 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE
12.1 OVERVIEW
12.2 DESKTOP
12.3 TABLET
12.4 SMART PHONE
12.5 HANDHELD PDA DEVICE
12.6 OTHERS
13 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY END USER
13.1 OVERVIEW
13.2 CONTRACT RESEARCH ORGANIZATIONS
13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
13.4 MEDICAL DEVICE MANUFACTURERS
13.5 HOSPITAL
13.6 CONSULTING SERVICE COMPANIES
13.7 ACADEMIC RESEARCH INSTITUTES
14 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY REGION
14.1 OVERVIEW
14.2 NORTH AMERICA
14.2.1 U.S.
14.2.2 CANADA
14.2.3 MEXICO
14.3 EUROPE
14.3.1 GERMANY
14.3.2 FRANCE
14.3.3 U.K.
14.3.4 ITALY
14.3.5 SPAIN
14.3.6 RUSSIA
14.3.7 TURKEY
14.3.8 NETHERLANDS
14.3.9 BELGIUM
14.3.10 SWITZERLAND
14.3.11 REST OF EUROPE
14.4 ASIA-PACIFIC
14.4.1 JAPAN
14.4.2 CHINA
14.4.3 INDIA
14.4.4 SOUTH KOREA
14.4.5 AUSTRALIA
14.4.6 SINGAPORE
14.4.7 THAILAND
14.4.8 MALAYSIA
14.4.9 INDONESIA
14.4.10 PHILIPPINES
14.4.11 REST OF ASIA-PACIFIC
14.5 SOUTH AMERICA
14.5.1 BRAZIL
14.5.2 ARGENTINA
14.5.3 REST OF SOUTH AMERICA
14.6 MIDDLE EAST AND AFRICA
14.6.1 SOUTH AFRICA
14.6.2 SAUDI ARABIA
14.6.3 U.A.E.
14.6.4 EGYPT
14.6.5 ISRAEL
14.6.6 REST OF MIDDLE EAST AND AFRICA
15 GLOBAL E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: EUROPE
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ORACLE
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 DASSAULT SYSTEMES
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 CLARIO
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 VEEVA SYSTEMS
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 ARISGLOBAL
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 4G CLINICAL
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 ADVARRA.
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANJU
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 CASTOR.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 DATATRAK INT.
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 ECLINICAL SOLUTIONS LLC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 IQVIA INC
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENTS
17.13 MAXISIT
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 MEDNET
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 MEDRIO, INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 MERATIVE
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 OPENCLINICA, LLC
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 PAREXEL INTERNATIONAL CORPORATION
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 QURETEC
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 REALTIME SOFTWARE SOLUTIONS, LLC
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 RESEARCH MANAGER
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SAAMA TECHNOLOGIES, LLC
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 SIGNANT HEALTH
17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENT
17.24 Y-PRIME, LLC.
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Список таблиц
TABLE 1 THE COSTS OF IMPLEMENTATION ARE AS FOLLOWS, ACCORDING TO SIMPLETRIALS:
TABLE 2 ACCORDING TO ECLINICAL WORKS – ECLINICAL OFFERS TWO ENTERPRISE PRICING PACKAGES:
TABLE 3 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL SAFETY SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL CLINICAL ANALYTICS PLATFORMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL CARE COORDINATION MEDICAL RECORD (CCMR) IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL OTHERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL WEB-HOSTED (ON-DEMAND) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL CLOUD-BASED (SAAS) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL PHASE III IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL PHASE I IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL PHASE II IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 GLOBAL PHASE IV IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 25 GLOBAL MEDIUM AND SMALL IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 GLOBAL LARGE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 28 GLOBAL DESKTOP IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 GLOBAL TABLET IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 GLOBAL SMART PHONE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 GLOBAL HANDHELD PDA DEVICE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 GLOBAL OTHERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 GLOBAL MEDICAL DEVICE MANUFACTURERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 GLOBAL HOSPITAL IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 GLOBAL CONSULTING SERVICE COMPANIES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 GLOBAL ACADEMIC RESEARCH INSTITUTES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 U.S. E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 U.S. E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 50 U.S. E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 51 U.S. E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 52 U.S. E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 53 U.S. E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 54 CANADA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 CANADA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 56 CANADA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 57 CANADA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 58 CANADA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 59 CANADA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 60 MEXICO E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 61 MEXICO E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 62 MEXICO E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 63 MEXICO E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 64 MEXICO E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 65 MEXICO E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 66 EUROPE E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 67 EUROPE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 68 EUROPE E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 69 EUROPE E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 70 EUROPE E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 71 EUROPE E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 72 EUROPE E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 73 GERMANY E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 74 GERMANY E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 75 GERMANY E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 76 GERMANY E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 77 GERMANY E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 78 GERMANY E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 79 FRANCE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 FRANCE E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 81 FRANCE E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 82 FRANCE E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 83 FRANCE E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 84 FRANCE E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 U.K. E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 86 U.K. E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 87 U.K. E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 88 U.K. E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 89 U.K. E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 90 U.K. E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 ITALY E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 ITALY E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 93 ITALY E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 94 ITALY E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 95 ITALY E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 96 ITALY E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 97 SPAIN E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 SPAIN E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 99 SPAIN E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 100 SPAIN E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 101 SPAIN E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 102 SPAIN E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 103 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 104 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 105 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 106 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 107 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 108 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 109 TURKEY E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 110 TURKEY E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 111 TURKEY E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 112 TURKEY E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 113 TURKEY E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 114 TURKEY E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 115 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 116 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 117 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 118 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 119 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 120 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 122 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 123 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 124 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 125 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 126 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 127 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 129 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 130 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 131 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 132 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 133 REST OF EUROPE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 134 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 135 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 136 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 137 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 138 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 139 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 140 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 141 JAPAN E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 142 JAPAN E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 143 JAPAN E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 144 JAPAN E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 145 JAPAN E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 146 JAPAN E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 147 CHINA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 148 CHINA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 149 CHINA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 150 CHINA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 151 CHINA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 152 CHINA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 153 INDIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 154 INDIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 155 INDIA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 156 INDIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 157 INDIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 158 INDIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 SOUTH KOREA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 160 SOUTH KOREA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 161 SOUTH KOREA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 162 SOUTH KOREA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 163 SOUTH KOREA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 164 SOUTH KOREA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 165 AUSTRALIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 166 AUSTRALIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 167 AUSTRALIA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 168 AUSTRALIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 169 AUSTRALIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 170 AUSTRALIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 171 SINGAPORE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 172 SINGAPORE E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 173 SINGAPORE E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 174 SINGAPORE E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 175 SINGAPORE E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 176 SINGAPORE E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 177 THAILAND E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 178 THAILAND E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 179 THAILAND E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 180 THAILAND E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 181 THAILAND E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 182 THAILAND E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 183 MALAYSIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 184 MALAYSIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 185 MALAYSIA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 186 MALAYSIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 187 MALAYSIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 188 MALAYSIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 189 INDONESIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 190 INDONESIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 191 INDONESIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 192 INDONESIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 193 INDONESIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 194 INDONESIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 195 PHILIPPINES E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 196 PHILIPPINES E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 197 PHILIPPINES E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 198 PHILIPPINES E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 199 PHILIPPINES E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 200 PHILIPPINES E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 201 REST OF ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 202 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 203 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 204 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 205 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 206 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 207 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 208 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 209 BRAZIL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 210 BRAZIL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 211 BRAZIL E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 212 BRAZIL E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 213 BRAZIL E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 214 BRAZIL E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 215 ARGENTINA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 216 ARGENTINA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 217 ARGENTINA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 218 ARGENTINA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 219 ARGENTINA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 220 ARGENTINA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 221 REST OF SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 222 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 223 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 224 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 225 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 226 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 227 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 228 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 230 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 231 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 232 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 233 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 234 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 235 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 236 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 237 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 238 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 239 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 240 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 241 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 242 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 243 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 244 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 245 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 246 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 247 EGYPT E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 248 EGYPT E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 249 EGYPT E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 250 EGYPT E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 251 EGYPT E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 252 EGYPT E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 253 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 254 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 255 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 256 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 257 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 258 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 REST OF MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
Список рисунков
FIGURE 1 GLOBAL E-CLINICAL SOLUTIONS MARKET: SEGMENTATION
FIGURE 2 GLOBAL E-CLINICAL SOLUTIONS MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL E-CLINICAL SOLUTIONS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL E-CLINICAL SOLUTIONS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL E-CLINICAL SOLUTIONS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL E-CLINICAL SOLUTIONS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL E-CLINICAL SOLUTIONS MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 GLOBAL E-CLINICAL SOLUTIONS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL E-CLINICAL SOLUTIONS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL E- CLINICAL SOLUTIONS MARKET: SEGMENTATION
FIGURE 11 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS AS WELL AS INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE, IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL E- CLINICAL SOLUTIONS MARKET FROM 2023 TO 2030
FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL E-CLINICAL SOLUTIONS MARKET IN 2023 AND 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL E- CLINICAL SOLUTIONS MARKET, AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR E-CLINICAL SOLUTIONS MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL E-CLINICAL SOLUTIONS MARKET
FIGURE 16 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2022
FIGURE 17 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 18 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 19 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 20 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2022
FIGURE 21 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2023-2030 (USD MILLION)
FIGURE 22 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, CAGR (2023-2030)
FIGURE 23 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 24 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2022
FIGURE 25 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, CAGR (2023-2030)
FIGURE 27 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, LIFELINE CURVE
FIGURE 28 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2022
FIGURE 29 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2023-2030 (USD MILLION)
FIGURE 30 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, CAGR (2023-2030)
FIGURE 31 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, LIFELINE CURVE
FIGURE 32 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2022
FIGURE 33 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2023-2030 (USD MILLION)
FIGURE 34 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, CAGR (2023-2030)
FIGURE 35 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, LIFELINE CURVE
FIGURE 36 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY END USER, 2022
FIGURE 37 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 38 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 39 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 GLOBAL E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 41 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY REGION (2022)
FIGURE 42 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY REGION (2023 & 2030)
FIGURE 43 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY REGION (2022 & 2030)
FIGURE 44 GLOBAL E-CLINICAL SOLUTIONS MARKET: BY PRODUCT (2023 & 2030)
FIGURE 45 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 46 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)
FIGURE 47 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 48 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 49 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)
FIGURE 50 EUROPE E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 51 EUROPE E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)
FIGURE 52 EUROPE E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 53 EUROPE E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 54 EUROPE E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)
FIGURE 55 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 56 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)
FIGURE 57 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 58 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 59 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)
FIGURE 60 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 61 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)
FIGURE 62 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 63 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 64 SOUTH AMERICA E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)
FIGURE 65 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 66 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)
FIGURE 67 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 68 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 69 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)
FIGURE 70 GLOBAL E-CLINICAL SOLUTIONS MARKET: COMPANY SHARE 2022 (%)
FIGURE 71 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: COMPANY SHARE 2022 (%)
FIGURE 72 EUROPE E-CLINICAL SOLUTIONS MARKET: COMPANY SHARE 2022 (%)
FIGURE 73 ASIA-PACIFIC E-CLINICAL SOLUTIONS MARKET: COMPANY SHARE 2022 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
